Previous Page  17 / 17
Information
Show Menu
Previous Page 17 / 17
Page Background

Page 54

Notes:

conferenceseries

.com

Euro Pathology 2018 | Hematologic Oncology 2018

June 20-21, 2018

Volume 8

Journal of Clinical & Experimental Pathology

ISSN : 2161-0681

15

th

EUROPEAN PATHOLOGY CONGRESS

&

LEUKEMIA AND HEMATOLOGIC ONCOLOGY

June 20-21, 2018 | Paris, France

14

th

International Conference on

JOINT EVENT

Mean platelet volume and mean platelet volume/platelet count ratio as markers for hepatocellular

carcinoma in patients with chronic hepatitis C virus related cirrhosis

Gamal Y Abo-Raia, Khaled Metwaly, Eman Abdel Sameea, Gasser El-Azab, Medhat Assem, Mohamed Abbas and Talaat Zakareya

Menoufia University, Egypt

H

epatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. The lack of efficient and precise HCC

biomarkers prevents early detection resulting in a poor prognosis. Recently, mean platelet volume (MPV) and MPV/platelet

count (PC) ratio have been proposed as potential markers of HCC. This study was carried out to verify MPV and MPV/PC ratio

in diagnosis of HCC in Egyptian patients with chronic hepatitis C related liver cirrhosis. One hundred and fifty chronic hepatitis C

(CHC) patients with chronic hepatitis, cirrhosis or HCC were enrolled in the study. The levels of alpha-feto protein (AFP), MPV and

MPV/PC ratio were determined compared to 50 healthy persons. MPV and MPV/CP ratios were higher in patients with cirrhosis and

those with HCC. The cut off level for MPV for detection of HCC was 10.1 fl, with sensitivity of 70% and specificity of 57%. At a cut

off level of 0.82, the sensitivity of MPV/CP ratio was 79.6% and specificity was 72.7%. AFP showed sensitivity 80% and specificity

82% at cut-off level of 16.9 ng/dl. MPV and MPV/PC ratios are less sensitive and specific than AFP as markers for HCC and they

may be used only in association with other markers to improve sensitivity of tumor detection.

Biography

Gamal Y Abo-Raia is an Assistant Professor of Clinical Pathology, Dept. of Clinical & Chemical Pathology, at National Liver Institute, Menoufia University. He is

Director of Clinical Chemistry Unit at National Liver Institute lab. He has published more than 20 papers in reputed journals. He is a supervisor of more than 20

Master’s & Doctorate theses.

dr_gamal_raia@yahoo.com

Gamal Y Abo-Raia et al., J Clin Exp Pathol 2018, Volume 8

DOI: 10.4172/2161-0681-C1-045